Company news
Somnomed Limited (ASX:SOM) news
Somnomed Limited news releases on 6ix. Latest, Aug 27, 2026: Full year results announcement FY26
Press releases & updates
Full year results announcement FY26
August 27, 2026
Executive management update & unaudited FY26 results
July 27, 2026
Investor presentation
February 26, 2026
Half Yearly Report and Accounts
February 26, 2026
Half year results announcement FY26
February 26, 2026
AGM Investor Presentation & addresses
November 27, 2025
Quarterly Update
October 29, 2025
Annual Report & full year results
August 27, 2025
Full year results announcement FY25
August 27, 2025
Quarterly Cashflow Report
July 28, 2025
Quarterly Activities Report
July 28, 2025
United States of America tariff update
April 7, 2025
FY25 Half Year Results
February 27, 2025
Quarterly Appendix 4C Cash Flow Report
January 23, 2025
FY25 Guidance Update and Quarterly Report
January 23, 2025
AGM Chairman & co-CEO addresses
November 26, 2024
Investor Presentation AGM
November 26, 2024
FY25 Guidance Upgrade and Appointment of CFO
November 26, 2024
Rest Assure - US Food and Drug Authority (FDA) Update
October 6, 2024
Investor Presentation
August 27, 2024
FY24 Preliminary Report and FY25 Guidance
August 27, 2024
Preliminary Final Report
August 27, 2024
Completion of retail component of Entitlement Offer
May 3, 2024
Replacement Prospectus
April 15, 2024
Reinstatement to Quotation
April 10, 2024
Completion of institutional component of Entitlement Offer
April 10, 2024
Revised guidance and capital raising
April 8, 2024
Prospectus Entitlement Offer
April 8, 2024
Update on voluntary suspension & FY24 earnings guidance
April 4, 2024
Suspension from Quotation
April 2, 2024
Trading Halt
March 26, 2024
Solid start in 1H as core business revenues increase 13%
February 27, 2024
Appointment of Co-CEO's
February 22, 2024
AGM presentation
November 24, 2023
AGM Chairman & CEO addresses
November 24, 2023
Quarterly cash report
October 29, 2023
Results of Retail Entitlement Offer
September 25, 2023
Successful completion of institutional Offer and Placement
September 3, 2023
FY23 results and Capital raising
August 30, 2023
Appendix 4C
July 25, 2023
Appendix 4C - March 2023
April 27, 2023
Growth momentum maintained
April 27, 2023
Revenue growth momentum continues in 1H FY23
February 22, 2023
Updated Quarterly Activities
February 1, 2023
Second quarter revenue growth of 17% to $21.4 million
January 29, 2023
Appendix 4C - December 2022
January 29, 2023
AGM Chairman and CEO addresses
November 24, 2022
AGM Investor Presentation
November 24, 2022
Appendix 4C....typographical correction
October 26, 2022
Appendix 4C Cash Flow Report
October 24, 2022